Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 33% ± 23% | |
microglial cell | 5 studies | 31% ± 12% | |
GABAergic neuron | 4 studies | 31% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 43% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 13% | 7.51 | 33 / 258 | 41% | 4.49 | 94 / 230 |
brain | 43% | 54.29 | 1137 / 2642 | 5% | 0.08 | 32 / 705 |
esophagus | 0% | 0.11 | 4 / 1445 | 1% | 0.01 | 1 / 183 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.01 | 2 / 286 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.02 | 3 / 430 |
prostate | 0% | 0.13 | 1 / 245 | 0% | 0 | 0 / 502 |
uterus | 0% | 0 | 0 / 170 | 0% | 0.00 | 1 / 459 |
thymus | 0% | 0.05 | 1 / 653 | 0% | 0 | 0 / 605 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 1 / 901 |
intestine | 0% | 0.02 | 1 / 966 | 0% | 0 | 0 / 527 |
breast | 0% | 0 | 0 / 459 | 0% | 0.00 | 1 / 1118 |
lung | 0% | 0 | 0 / 578 | 0% | 0.00 | 1 / 1155 |
skin | 0% | 0.01 | 1 / 1809 | 0% | 0 | 0 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019233 | Biological process | sensory perception of pain |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0007197 | Biological process | adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0048149 | Biological process | behavioral response to ethanol |
GO_2000310 | Biological process | regulation of NMDA receptor activity |
GO_0050769 | Biological process | positive regulation of neurogenesis |
GO_0071315 | Biological process | cellular response to morphine |
GO_0007600 | Biological process | sensory perception |
GO_0061358 | Biological process | negative regulation of Wnt protein secretion |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0080135 | Biological process | regulation of cellular response to stress |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0038003 | Biological process | G protein-coupled opioid receptor signaling pathway |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0043204 | Cellular component | perikaryon |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0043005 | Cellular component | neuron projection |
GO_0030425 | Cellular component | dendrite |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0045202 | Cellular component | synapse |
GO_0030424 | Cellular component | axon |
GO_0005768 | Cellular component | endosome |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0031681 | Molecular function | G-protein beta-subunit binding |
GO_0001965 | Molecular function | G-protein alpha-subunit binding |
GO_0042923 | Molecular function | neuropeptide binding |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0038047 | Molecular function | morphine receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0004979 | Molecular function | beta-endorphin receptor activity |
Gene name | OPRM1 |
Protein name | Mu opioid receptor Mu opioid receptor MOR-1O Opioid receptor mu 1 Opioid receptor mu Mu opioid receptor splice variant hMOR-1S Mu-type opioid receptor Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP) Mu opioid receptor splice variant MOR-1H Mutant opioid receptor mu |
Synonyms | MOR1 OPRM MOP MOR |
Description | FUNCTION: Receptor for endogenous opioids such as beta-endorphin and endomorphin . Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone . Also activated by enkephalin peptides, such as Met-enkephalin or Met-enkephalin-Arg-Phe, with higher affinity for Met-enkephalin-Arg-Phe (By similarity). Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors . The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extent to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15 . They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B (By similarity). Also couples to adenylate cyclase stimulatory G alpha proteins (By similarity). The selective temporal coupling to G-proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4 (By similarity). Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization (By similarity). Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G-protein thus terminating signal transduction (By similarity). The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins (By similarity). The activation of the ERK pathway occurs either in a G-protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation (By similarity). Acts as a class A G-protein coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling (By similarity). Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G-protein coupling (By similarity). Endogenous ligands induce rapid desensitization, endocytosis and recycling (By similarity). Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties (By similarity). .; FUNCTION: [Isoform 12]: Couples to GNAS and is proposed to be involved in excitatory effects. .; FUNCTION: [Isoform 16]: Does not bind agonists but may act through oligomerization with binding-competent OPRM1 isoforms and reduce their ligand binding activity. .; FUNCTION: [Isoform 17]: Does not bind agonists but may act through oligomerization with binding-competent OPRM1 isoforms and reduce their ligand binding activity. . |
Accessions | A0A0F6TMB4 B7SXT1 ENST00000337049.8 [P35372-5] ENST00000522739.5 [P35372-6] ENST00000518759.5 [P35372-13] A0A6H0WCP3 B8K2Q5 ENST00000330432.12 [P35372-1] ENST00000435918.6 [P35372-8] A0A0F6TN24 ENST00000229768.9 [P35372-3] ENST00000519083.5 [P35372-6] ENST00000434900.6 [P35372-10] ENST00000522555.5 [P35372-12] G8XRH5 A0A0F6RA07 O43185 Q71V90 ENST00000414028.6 [P35372-4] Q716A7 A0A0F6TMM4 ENST00000360422.8 B7SXT4 ENST00000428397.6 [P35372-2] P35372 ENST00000524150.2 [P35372-18] E7EW71 ENST00000522236.1 [P35372-12] B7SXT0 A0A6H0WF09 ENST00000452687.6 [P35372-7] C9EA00 L0E130 A0A089PQW6 B7SXT3 C7E9I8 ENST00000524163.5 [P35372-11] C9E9Z9 G8XRH4 ENST00000419506.6 [P35372-9] B7SXT2 ENST00000520708.5 [P35372-12] A0A0F6RAI2 ENST00000520282.5 A0A0F6TMT4 |